Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet Consistency of Response in Acute Migraine
NCT00240617Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Treximet with Placebo (2 arms). Primary endpoint: Score on a 4 pt migraine pain scale at 24 hours. Started Oct 2005; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00240617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240617.